Orchestrating epigenetic roles targeting ocular tumors.

Area of Science:

• Biomedical Research
• Cancer Biology
• Ophthalmology

Background:

• Epigenetics, the study of heritable changes in gene expression without altering the DNA sequence, is a rapidly advancing field in biomedical research.
• Historically focused on DNA methylation, epigenetic research now encompasses histone modifications, non-coding RNA, and chromatin remodeling.
• Epigenetic mechanisms play a significant role in the development and progression of various cancers, including ocular tumors.

Purpose of the Study:

• To review the current understanding of epigenetic mechanisms in ocular tumors.
• To highlight the expansion of epigenetic studies from single genes to genome-wide analyses in this context.
• To summarize the development of novel pharmacological strategies targeting epigenetic alterations in ocular cancers.

Main Methods:

• Comprehensive literature review of epigenetic studies in ocular tumors.
• Analysis of research focusing on DNA methylation, histone modification, non-coding RNA, and chromatin remodeling.
• Examination of therapeutic strategies and epigenetic drug development for ocular cancers.

Main Results:

• Epigenetic alterations are prevalent in ocular tumors such as retinoblastoma and uveal melanoma.
• Epigenetic research in ocular tumors has progressed from gene-specific to genome-wide investigations.
• The reversible nature of epigenetic changes has led to the development of targeted epigenetic therapies.

Conclusions:

• Epigenetic mechanisms are fundamental to ocular tumor biology and represent promising therapeutic targets.
• Reversible epigenetic modifications offer a unique window for developing innovative pharmacological strategies.
• Further research into epigenetic dysregulation in ocular cancers is essential for advancing treatment outcomes.